Items in cart [0] Questions? Call 888-624-8373

PAPERBACK list:$43.00 Web:$38.70 add to cart Rights & Permissions Free PDF Access Free Resources Sign in to download PDF book and chapters PDF EXECUTIVE SUMMARY Display this book on your site! Related Titles Immunization Safety Review: Vaccines and Autism Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders Other Related Titles Immunization Safety Review: Influenza Vaccines and Neurological Complications (2004) Board on Health Promotion and Disease Prevention (HPDP) Institute of Medicine (IOM) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 168   E-mail  Facebook  Digg  Stumble  Twitter More Page 168 Front Matter (R1-R14) Executive Summary (1-22) Contents of Report (23-146) References (147-154) Appendix A: Committee Recommendations and Conclusions from Previous Reports (155-167) Appendix B: Public Meeting Agenda, March 13, 2003 (168-169) Appendix C: Chronology of Important Events Regarding Vaccine Safety (170-174) Appendix D: Acronyms (175-176)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 168
Appendix B Public Meeting Agenda March 13, 2003 Immunization Safety Review Influenza Vaccine and Possible Neurological Complications Hotel Monaco Athens Room, 700 F St., NW Washington, DC 9:00 - 9:15 am Welcome and Opening Remarks Marie McCormick, MD, ScD, Committee Chair 9:15 - 9:45 am Influenza Robert G. Webster, PhD St. Jude Children's Research Hospital 9:45 - 10:15 am Guillain-Barre Syndrome John Griffin, MD The Johns Hopkins University School of Medicine 10:15 - 10:45 am The Yearly Production of Influenza Vaccine Roland Levandowski, MD Food and Drug Administration 10:45 - 11:00 am Break 168

OCR for page 169
APPENDIX B 11:00- 11:30 am 11:30- 12:15 pm 12:15 - 1:30 pm 1:30 - 2:15 pm 169 VAERS Reports Related to Influenza Vaccine Penina Haber,MPH Centers for Disease Control and Prevention Discussion Lunch Studies of Guillain-Barre Syndrome After Influenza Vaccination Robert Chen, MD Centers for Disease Control and Prevention 2:15 - 2:45 pm Guillain-Barre Syndrome and the 1992-1993 and 1993-1994 Influenza Vaccines Tamar Lasky, PhD National Institute of Child Health & Human Development 2:45 - 3:15 pm Safety of Influenza Vaccine in the Pediatric Population Eric K. France, MD, MSPH Preventive Medicine Kaiser Permanente Colorado 3:15 - 3:30 pm Break 3:30 - 4:00 pm Intranasal Vaccines Kathryn Edwards, MD, (presented via conference call) Vanderbilt University School of Medicine 4:00 - 4:30 pm VSD Data Related to Influenza Vaccine and Incidence/Relapse of MS Frank DeStefano, MD Centers for Disease Control and Prevention 4:30 - 4:45 pm Use of Medicare Data to Evaluate Adverse Events After Influenza Vaccine Dale Burwen, MD, Food and Drug Administration 4:45 - 5:30 pm Discussion and Public Comment 5:30 pm Adjourn

Representative terms from entire chapter:

vanderbilt university